Foundation for Research in Liver Diseases

Copper metabolism: Prof. M. Solioz
Home
About us
Liver diseases
Examinations
Prevention
Research
Cancer and angiogenesis
Drugs and antioxidants
Novel Treatments
Copper
Alcohol
Analytics
 
 
 
The human body needs copper - but too much could be dangerous!

Copper was the first metal used by humans 7'000 years ago. It is also an essential trace element (the third most important after iron and zinc). The daily need is 1.5 - 3.0 mg/d. It is absorbed in the intestine, transported to the liver which distributes it to all other organs. Any excess is excreted into the bile. Copper deficiency leads to anemia, delayed wound healing und weakness of connective tissue.

In a rare hereditary disease (Wilson's disease which affects 1/30,000) the liver is unable to excrete any copper excess. Copper then accumulates in the liver (leading to cirrhosis or fulminant hepatic failure) and in the brain (leading to neurological or psychiatric disturbances).


Kayser-Fleischer ring: copper deposition in the iris in Wilson disease

We are interested in three aspects of copper metabolism:
  • Definition of the mechanisms of copper homeostasis
  • Identification of biomarkers of the state of copper in an organism
  • New diagnostic methods to detect Wilson disease
Copper homeostasis

Copper is taken up into cells by specialized transport proteins. Copper taken up into a cell binds to special proteins - copper chaperones. Other transport systems are responsible for the routing of copper to other cellular compartments or to incorporate it into enzymes dependent on copper. If there is excess copper, yet other copper transporters pump it out of the cell.

Most of these proteins involved in copper metabolism are highly conserved and evolved very early. Thus, similar proteins can be found in bacteria, plants and animals up to man. We are interested in studying these molecular mechanisms in two bacterial model systems, namely  Enterococcus hirae and Lactococcus lactis. More information on this can be found on our lab website.

Biomarkers
There are no established methods to get a sense of the copper status (deficiency or excess) of any organism. Therefore, we are searching for such indicators using biomarkers.  Biomarkers are proteins responding to the level of copper in an organism. Using 2D-gels we analyze the composition of the lining cells of the gut as a function of copper availability. Using this technique we observe some proteins which are up- or downregulated. 
 
Stiftung für
Leberkrankheiten
Institut für Klinische Pharmakologie
Universität Bern

Murtenstrasse 35,
Postfach 49
3010 Bern
0041 (0)31 632 31 91
Info@leberstiftung.ch